Jw Holdings - Asset Resilience Ratio

Latest as of September 2025: 1.56%

Jw Holdings (096760) has an Asset Resilience Ratio of 1.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 096760 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩19.24 Billion
≈ $13.04 Million USD Cash + Short-term Investments

Total Assets

₩1.23 Trillion
≈ $833.08 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Jw Holdings's Asset Resilience Ratio has changed over time. See net asset quality index of Jw Holdings to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Jw Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 096760 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩19.24 Billion 1.56%
Total Liquid Assets ₩19.24 Billion 1.56%

Asset Resilience Insights

  • Limited Liquidity: Jw Holdings maintains only 1.56% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jw Holdings Industry Peers by Asset Resilience Ratio

Compare Jw Holdings's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Aurobindo Pharma Limited
NSE:AUROPHARMA
Drug Manufacturers - Specialty & Generic 1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
Drug Manufacturers - Specialty & Generic -0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
Drug Manufacturers - Specialty & Generic 0.20%
Xeris Pharmaceuticals Inc
NASDAQ:XERS
Drug Manufacturers - Specialty & Generic 0.00%
Procter & Gamble Health Limited
NSE:PGHL
Drug Manufacturers - Specialty & Generic 33.01%

Annual Asset Resilience Ratio for Jw Holdings (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Jw Holdings.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.41% ₩30.14 Billion
≈ $20.43 Million
₩1.25 Trillion
≈ $847.52 Million
-4.44pp
2023-12-31 6.85% ₩80.61 Billion
≈ $54.62 Million
₩1.18 Trillion
≈ $797.14 Million
-2.00pp
2022-12-31 8.85% ₩102.48 Billion
≈ $69.45 Million
₩1.16 Trillion
≈ $784.48 Million
+3.47pp
2021-12-31 5.39% ₩57.41 Billion
≈ $38.91 Million
₩1.07 Trillion
≈ $722.26 Million
+0.34pp
2020-12-31 5.04% ₩56.44 Billion
≈ $38.25 Million
₩1.12 Trillion
≈ $758.15 Million
+4.05pp
2019-12-31 0.99% ₩12.36 Billion
≈ $8.38 Million
₩1.24 Trillion
≈ $842.68 Million
-0.80pp
2018-12-31 1.79% ₩22.83 Billion
≈ $15.47 Million
₩1.28 Trillion
≈ $864.48 Million
+0.58pp
2017-12-31 1.21% ₩16.40 Billion
≈ $11.12 Million
₩1.35 Trillion
≈ $915.81 Million
-2.93pp
2016-12-31 4.15% ₩49.63 Billion
≈ $33.64 Million
₩1.20 Trillion
≈ $810.94 Million
+3.89pp
2015-12-31 0.26% ₩2.76 Billion
≈ $1.87 Million
₩1.08 Trillion
≈ $733.84 Million
-0.03pp
2014-12-31 0.28% ₩2.93 Billion
≈ $1.98 Million
₩1.04 Trillion
≈ $702.09 Million
-0.10pp
2013-12-31 0.38% ₩3.84 Billion
≈ $2.60 Million
₩1.01 Trillion
≈ $687.47 Million
+0.07pp
2012-12-31 0.31% ₩3.29 Billion
≈ $2.23 Million
₩1.08 Trillion
≈ $729.96 Million
+0.01pp
2011-12-31 0.29% ₩3.20 Billion
≈ $2.17 Million
₩1.09 Trillion
≈ $741.92 Million
-0.17pp
2010-12-31 0.46% ₩3.41 Billion
≈ $2.31 Million
₩736.86 Billion
≈ $499.36 Million
-0.13pp
2009-12-31 0.59% ₩4.17 Billion
≈ $2.83 Million
₩709.64 Billion
≈ $480.91 Million
-1.76pp
2008-12-31 2.35% ₩15.08 Billion
≈ $10.22 Million
₩642.09 Billion
≈ $435.13 Million
-3.11pp
2007-12-31 5.46% ₩30.30 Billion
≈ $20.54 Million
₩554.89 Billion
≈ $376.04 Million
--
pp = percentage points

About Jw Holdings

KO:096760 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$183.10 Million
₩270.19 Billion KRW
Market Cap Rank
#16995 Global
#669 in Korea
Share Price
₩3905.00
Change (1 day)
-1.01%
52-Week Range
₩3165.00 - ₩4470.00
All Time High
₩26485.64
About

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more